2009
DOI: 10.1002/hep.23136
|View full text |Cite
|
Sign up to set email alerts
|

Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

9
191
5
6

Year Published

2010
2010
2017
2017

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 241 publications
(212 citation statements)
references
References 26 publications
9
191
5
6
Order By: Relevance
“…We also evaluated changes in liver fibrosis at fixed intervals, at 3 and 5 years after liver transplantation, in relation to clinical decompensation, in order to make the time frame for evaluation more homogenous. The Ishak stage change calculation was evaluated as it has been used to assess fibrosis progression in the literature and we wished to compare our results with those of others [15,16] [2]. However, we acknowledge that since Ishak stage scores are not numerical measurements, without an arithmetical relationship between them (the ''scores'' are merely categorical labels), this method is an approximation [1][2][3].…”
Section: Methodsmentioning
confidence: 99%
“…We also evaluated changes in liver fibrosis at fixed intervals, at 3 and 5 years after liver transplantation, in relation to clinical decompensation, in order to make the time frame for evaluation more homogenous. The Ishak stage change calculation was evaluated as it has been used to assess fibrosis progression in the literature and we wished to compare our results with those of others [15,16] [2]. However, we acknowledge that since Ishak stage scores are not numerical measurements, without an arithmetical relationship between them (the ''scores'' are merely categorical labels), this method is an approximation [1][2][3].…”
Section: Methodsmentioning
confidence: 99%
“…In patients with chronic HCV infection, concomitant HIV infection is associated with higher rates of morbidity and mortality related to end-stage liver disease [11].…”
Section: Discussionmentioning
confidence: 99%
“…Olgumuzda da ilk başvuruda CD4 T-lenfosit sayısı <200 hücre/mm3 olduğundan öncelikle ART başlandı, HCV tedavisi ertelendi, CD4 T-lenfosit sayısı yükseldikten sonra tedavi planlandı. Antiretroviral tedavinin immünfonksiyonları düzenlemek yoluyla karaciğer hastalığının progresyonunu yavaşlattığı bilinmektedir (23)(24)(25). Bu nedenle de KHC varlığında CD4 T-lenfosit sayısından bağımsız olarak ART önerilmektedir.…”
Section: Discussionunclassified